Company Filing History:
Years Active: 2018
Title: Sabi Airouche: Innovator in Allergen Immunotherapy
Introduction
Sabi Airouche is a notable inventor based in Paris, France. He has made significant contributions to the field of allergen immunotherapy through his innovative research and development efforts. His work focuses on creating effective solutions for allergy diagnosis and treatment.
Latest Patents
Sabi Airouche holds a patent for a groundbreaking invention titled "Recombinant Der P 2 expressed in Pichia Pastoris as a 'natural-like' allergen for immunotherapy and diagnostic purposes." This patent involves a method for producing a recombinant protein (rDer p 2) by cultivating a yeast strain transformed with a rDer p 2 coding sequence. The process includes isolating the rDer p 2 protein from the yeast strain. Additionally, the invention encompasses compositions and kits that utilize the rDer p 2 protein for therapeutic or diagnostic applications. He has 1 patent to his name.
Career Highlights
Sabi Airouche is associated with Stallergenes, a company dedicated to developing innovative treatments for allergies. His work at Stallergenes has positioned him as a key player in the field of allergen immunotherapy. His research has the potential to improve the quality of life for individuals suffering from allergies.
Collaborations
Sabi Airouche has collaborated with notable colleagues, including Véronique Bordas and Laetitia Bussieres. These collaborations have further enhanced his research and development efforts in the field of immunotherapy.
Conclusion
Sabi Airouche is a distinguished inventor whose work in allergen immunotherapy is paving the way for new diagnostic and therapeutic solutions. His contributions are vital in addressing the challenges posed by allergies, and his innovative spirit continues to inspire advancements in the field.